1. Home /
  2. Investing /
  3. Cannabis


Arizona Has the Fastest Start to the Adult-Use Cannabis Market

The companies that staked a flag in the state for the medical program were in a great position to quickly hit the ground running.

Bright Cannabis Outlook Leads to Bigger Estimates for 2022

The fundamentals of the cannabis industry continue to improve.

What's Up With the SPAC Silver Spike Acquisition?

WM Holdings, a cloud software provider for the cannabis industry, will soon be coming public by a reverse merger with SSPK.

My 'Aggressive', Under-the-Radar Stock Pick for 2021

This cannabis-related model that sheds the commodity moniker and actually is a life sciences company.

Cannabis Leader Canopy Growth Can Climb Higher

Here's how to play CGC.

KushCo Sprinkles Some Gems on Its Earnings Call

The cannabis packaging company is looking at Arizona and New Jersey as new markets for growth.

I'm Coming Back Around to LiDAR Related Names

Three stocks top my list for plays: Velodyne Lidar, Luminar Technologies, and Collective Growth Crop.

Jushi Holdings Puts Growth Plans in High Gear

The cannabis cultivator and retailer plans to nearly double its number of dispensaries in 2021.

As the Focus on Psychedelic Stocks Increases, So Do the Valuations

The only companies that have Phase 2 clinical trials now are Compass Pathways, Mind Medicine, Cybin, and Mydecine Innovations.

Democrat Wins Means Cannabis Wins

Georgia's election results have given the industry a big green light, meaning positive moves are expected out of cannabis stocks.

Constellation Brands Makes a Major Upside Breakout

Let's take a fresh look at the charts and indicators.

Canopy Growth Breaks Out on the Upside

Continue to hold longs in previous recommendations.

It's All About Sector Rotation

I'm focused on stock picking and continue to hunt for more sector plays.

Georgia Contest Could Fire Up Cannabis Stocks

If Democrats score, marijuana names could benefit.

This Continues to Be a Good Market for Stock Picking

There is some good dip buying on my screens in the early going.

There's Plenty of Choppy Action

I believe that this shakeout may last a couple of days.

Animal Feed Might Just Go to Pot -- And That's a Good Thing

It might be time to look beyond CBD for hemp stocks as the future may instead be at the feed lots.

Shark Bites: Here's Why I've Been a Buyer of Village Farms

VFF was not a very exciting business until it entered into a joint venture with Emerald Health Therapeutics.

A Cannabis Consolidation Binge Is Creating Top Tier Companies

Two more major deals were announced on Tuesday.

Adding to an Old Favorite and Taking Some Profits in Cannabis

Aurinia Pharma has some positive catalysts, and I am taking partial gains in cannabis names as they remain strong.

Tilray Wins, Even Though Aphria Is the Boss

Aphria investors will have a larger stake in the combined company post-merger.

Cannabis Stocks Are Showing Signs of Life

I am watching names like Curaleaf and the MSOS cannabis ETF, which could keep moving higher.

Seelos Therapeutics Seeks Suicide Solution in Ketamine

It's a wonder how many lives could be saved if patients were given this drug at a time of dire need.

MORE Act Passes, But It's Mostly Symbolic

This is the first time that any cannabis bill addressing descheduling has been approved by Congress.

With High Hopes, Hemp Looks Ahead to 2021

There were several reasons why the 2020 supply fell from 2019 levels.

I'm Looking at a Swing Trading Position in Tilray

TLRY has an active options market, so risk can be defined.

The Canopy Growth Rally Catches a Second Wind

Traders could approach CGC from the long side.

Voters Spoke and the Winner Is Cannabis

A 'green wave' has advanced cannabis legalization across America. And that's just one of the forces powering up pot stocks right now.

Third Quarter Signals a Turning Point for Cannabis Companies

It has been a challenging road for these firms, but now it appears that positive things are about to happen.

Many Traders Are Locking in Gains as Traditional Holiday Trading Isn't There

The primary problem is that there was just too much wild speculative action on Monday and Tuesday.